跳至主要内容
临床试验/NL-OMON43421
NL-OMON43421已完成4 期

The role of dynamic hyperinflation in asthma - Dynamic hyperinflation in asthma

Medisch Centrum Leeuwarden0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Adults with symptoms compatible with asthma or COPD
  • Non-smoking, *10 packyears
  • ICS (*500 mcg fluticasone equivalent) or daily oral corticosteroids combined with LABA or other controller for at least 6 months.
  • Stable disease, no exacerbations in last 4 weeks
  • FEV1/FVC *80% predicted pre-bronchodilation
  • MPT induced dynamic hyperinflation: * IC *-10%
  • CPET induced dynamic hyperinflation: * IC *-10%

排除标准

  • Concurrent respiratory diseases
  • Clinically significant cardiovascular disease
  • Pregnant or breastfeeding women
  • History of hypertension, diabetes mellitus, menorrhagia, immunodeficiency, psychiatric diseases, idiopathic thrombocytopenic purpura, ulcus ventriculi, ulcus duodeni, infectious disease and infection after administration of live or live, attenuated vaccines.
  • Hypersensitivity to any components of triamcinolon acetonide,

研究者

发起方
Medisch Centrum Leeuwarden

相似试验